Nevan C Elam's Net Worth

$482 Thousand

Estimate Recalculated Nov 1, 2024 10:13AM EST

Who is Nevan C Elam

Nevan C Elam does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NEKTAR THERAPEUTICS, Rezolute, Inc., Savara Inc, and Peak Bio, Inc..

SEC CIK

Nevan C Elam's CIK is 0001314773

Past Insider Trading and Trends

2021 was Nevan C Elam's most active year for acquiring shares with 5 total transactions. Nevan C Elam's most active month to acquire stocks was the month of November. 2021 was Nevan C Elam's most active year for disposing of shares, totalling 8 transactions. Nevan C Elam's most active month to dispose stocks was the month of November. 2005 saw Nevan C Elam paying a total of $2,977,600.00 for 160,000 shares, this is the most they've acquired in one year. In 2023 Nevan C Elam cashed out on 158,442 shares for a total of $442,291.44, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEKTAR THERAPEUTICS

SVP & Head Pulmonary Bus
Updated Feb 27, 2008
Form 4
85.00K
$6.46
$549.10K
Feb 27, 2008
85.00K
Grant
Feb 25
Form 4
150.00K
Dec 26, 2007
150.00K
Grant
Dec 21
Form 4
$0.01
May 15, 2007
7.00K
Acq/Dis
May 14
Form 4
43.48%
40.00K
$13.02
$520.80K
Apr 04, 2007
132.00K
Grant
Apr 02
Form 4
15.00%
12.00K
$17.52
$210.24K
Sep 06, 2006
92.00K
Grant
Sep 01
Form 4
7.00K
$0.01
$70.00
Mar 13, 2006
7.00K
Grant
Mar 10
Form 4/A
80.00K
$18.61
$1.49M
Jan 19, 2005
Grant
Jan 17
Form 3/A
Jan 19, 2005
Form 4
80.00K
$18.61
$1.49M
Jan 19, 2005
Grant
Jan 17
Form 3
Jan 19, 2005
Showing 10 results

Rezolute, Inc.

CEO
Updated Feb 28, 2024
Form 4
177.49%
5.00K
$1.68
$8.40K
Feb 28, 2024
7.82K
Purchase
Feb 26
Form 4
340.00K
Jan 25, 2024
340.00K
Grant
Jan 23
Form 4
2.60M
Jun 27, 2022
2.60M
Grant
Jun 23
Form 4/A
15.76%
170.20K
Aug 31, 2021
1.25M
Acquisition
Jun 14
Form 4
15.76%
170.20K
Jul 14, 2021
1.25M
Acquisition
Jun 14
Form 4
15.00M
Sep 16, 2019
15.00M
Grant
Jul 31
Form 4
3.50M
Jan 13, 2017
3.50M
Grant
Oct 31
Form 4
-91.28%
-805.14K
$1.95
$150.00K
Jan 11, 2016
76.92K
Sale
Feb 09 - Dec 10
Form 4
38.57%
1.35M
May 02, 2014
4.85M
Grant
Apr 30
Form 4
32.31%
1.29M
$0.26
$275.00K
Apr 10, 2014
5.29M
Acquisition
Mar 31
Form 3
Feb 08, 2013
4.00M
Showing 11 results

Savara Inc

Investor
Updated Dec 29, 2023
Form 4
-80.66%
-93.84K
$3.01
-$372.57K
Dec 29, 2023
22.50K
Sale
Dec 28
Form 4
56.13%
22.50K
Dec 15, 2023
62.59K
Grant
Dec 14
Form 4
$0.82
$8.89K
Dec 12, 2023
40.09K
Options
Dec 11
Form 4
136.78%
40.00K
$0.65
$761.80
Dec 15, 2022
69.24K
Options
Dec 13
Form 4
40.00K
Dec 14, 2021
40.00K
Grant
Dec 14
Form 4
$0.55
$644.60
Dec 08, 2021
28.07K
Options
Dec 06
Form 4
$0.52
$1.19K
Aug 19, 2021
26.90K
Options
Aug 18
Form 4
162.52%
40.00K
$0.52
$1.52K
Dec 17, 2020
64.61K
Options
Dec 15 - Dec 16
Form 4
12.00K
Dec 26, 2019
12.00K
Grant
Dec 20
Form 4
$0.19
$4.12K
Feb 05, 2019
21.68K
Options
Feb 04
Form 4
12.00K
Dec 14, 2018
12.00K
Grant
Dec 13
Form 4
3.75K
Dec 19, 2017
3.75K
Grant
Dec 17
Form 3
May 05, 2017
Showing 13 results

Peak Bio, Inc.

Investor
Updated Nov 03, 2022
Form 3
Nov 03, 2022
Showing 1 results